GN
Genelux Corporation (GNLX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$2.01
+10.16%
Mkt Cap $88.68M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $8.00K | $8.00K | +0.00% | -$0.22 | -$0.24 | -9.09% |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.23 | -$0.21 | +8.70% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.22 | -$0.20 | +9.09% |
| Q2 2025 May 6, 2025 | — | — | — | -$0.24 | -$0.21 | +12.50% |
| Q1 2025 Mar 28, 2025 | — | $452.00K | — | -$0.17 | -$0.26 | -52.94% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.19 | -$0.19 | +0.00% |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.19 | -$0.22 | -15.79% |
| Q2 2024 May 9, 2024 | — | $8.00K | — | -$0.23 | -$0.29 | -26.09% |
| Q1 2024 Mar 29, 2024 | — | $1.46M | — | -$0.21 | -$0.25 | -19.05% |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.12 | -$0.20 | -66.67% |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.15 | -$0.23 | -53.33% |
| Q2 2023 May 15, 2023 | $170.00K | $170.00K | +0.00% | -$0.16 | -$0.53 | -230.89% |
| Q1 2023 Jan 26, 2023 | — | $68.00K | — | -$0.17 | -$0.13 | +22.12% |
| Q3 2022 Sep 30, 2022 | — | $11.00M | — | — | $0.16 | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.13 | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.13 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.12 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.14 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.31 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.10 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.14 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.14 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.14 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.16 | — |